NO20024732L - Ny kombinasjon av en betablokker og et kolesterolsenkende middel - Google Patents

Ny kombinasjon av en betablokker og et kolesterolsenkende middel

Info

Publication number
NO20024732L
NO20024732L NO20024732A NO20024732A NO20024732L NO 20024732 L NO20024732 L NO 20024732L NO 20024732 A NO20024732 A NO 20024732A NO 20024732 A NO20024732 A NO 20024732A NO 20024732 L NO20024732 L NO 20024732L
Authority
NO
Norway
Prior art keywords
blocker
cholesterol
beta
lowering agent
new combination
Prior art date
Application number
NO20024732A
Other languages
English (en)
Norwegian (no)
Other versions
NO20024732D0 (no
Inventor
Goeran Bondjers
Olov Wiklund
John Wikstrand
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0001188A external-priority patent/SE0001188D0/xx
Priority claimed from SE0002352A external-priority patent/SE0002352D0/xx
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20024732L publication Critical patent/NO20024732L/no
Publication of NO20024732D0 publication Critical patent/NO20024732D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20024732A 2000-04-03 2002-10-02 Ny kombinasjon av en betablokker og et kolesterolsenkende middel NO20024732D0 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0001188A SE0001188D0 (sv) 2000-04-03 2000-04-03 New combination
SE0002352A SE0002352D0 (sv) 2000-06-22 2000-06-22 New combination
PCT/SE2001/000663 WO2001074394A1 (en) 2000-04-03 2001-03-27 New combination of a betablocker and a cholesterol-lowering agent

Publications (2)

Publication Number Publication Date
NO20024732L true NO20024732L (no) 2002-10-02
NO20024732D0 NO20024732D0 (no) 2002-10-02

Family

ID=26655059

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20024732A NO20024732D0 (no) 2000-04-03 2002-10-02 Ny kombinasjon av en betablokker og et kolesterolsenkende middel

Country Status (25)

Country Link
US (2) US20030060477A1 (is)
EP (1) EP1272219B1 (is)
JP (1) JP2003528928A (is)
KR (1) KR20020086749A (is)
CN (1) CN1422161A (is)
AR (1) AR030414A1 (is)
AT (1) ATE347909T1 (is)
AU (2) AU4298501A (is)
BR (1) BR0109753A (is)
CA (1) CA2403160A1 (is)
DE (1) DE60125159T2 (is)
EE (1) EE200200570A (is)
ES (1) ES2276774T3 (is)
HK (1) HK1051325A1 (is)
HU (1) HUP0300332A3 (is)
IL (1) IL151589A0 (is)
IS (1) IS6554A (is)
MX (1) MXPA02009705A (is)
MY (1) MY136386A (is)
NO (1) NO20024732D0 (is)
NZ (1) NZ521351A (is)
PL (1) PL357813A1 (is)
RU (1) RU2002123591A (is)
SK (1) SK14102002A3 (is)
WO (1) WO2001074394A1 (is)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7790197B2 (en) 2003-06-09 2010-09-07 Warner-Lambert Company Llc Pharmaceutical compositions of atorvastatin
US7314640B2 (en) * 2003-07-11 2008-01-01 Mongkol Sriwongjanya Formulation and process for drug loaded cores
GB0322552D0 (en) 2003-09-26 2003-10-29 Astrazeneca Uk Ltd Therapeutic treatment
ITMI20040145A1 (it) * 2004-01-30 2004-04-30 Acraf L-moprololo lpiu' tartrato
WO2005077331A1 (en) * 2004-02-11 2005-08-25 Athpharma Limited Chronotherapeutic compositions and methods of their use
US7288553B2 (en) * 2004-05-03 2007-10-30 Janssen Pharmaceutica N.V. Indole derivatives as selective androgen receptor modulator (SARMS)
CN101022791B (zh) * 2004-06-04 2011-11-16 麦兰实验室公司 含奈必洛尔的组合物
US20090318496A1 (en) 2006-08-04 2009-12-24 Aska Pharmaceutical Co., Ltd. Preparation containing fibrate agent and process for producing the same
GB0624282D0 (en) * 2006-12-05 2007-01-10 Cavalla David Treatment of cachexia
KR20100045344A (ko) * 2008-10-23 2010-05-03 한올바이오파마주식회사 방출성이 제어된 베타 아드레날린 차단제와 ＨＭＧ-ＣｏＡ 환원 효소 억제제의 신규 복합 조성물
MX344885B (es) * 2008-11-10 2017-01-10 Psicofarma S A De C V Proceso para la obtencion de una composicion de rosuvastatina calcica y producto obtenido.
CN102462844A (zh) * 2010-11-05 2012-05-23 四川滇虹医药开发有限公司 一种替利洛尔的药物组合物及其制备方法
WO2013157833A1 (ko) * 2012-04-18 2013-10-24 서울대학교산학협력단 베타-차단제를 유효성분으로 포함하는 비만, 비만으로 인한 대사성 질환 및 골감소증 예방, 개선 또는 치료용 조성물
CN103613586B (zh) * 2013-11-01 2016-06-08 北京博爱旺康医药科技有限公司 一种旋光纯s-(-)-阿罗洛尔酸式盐及其制备方法和应用
CN103626750B (zh) * 2013-11-15 2016-02-24 北京博爱旺康医药科技有限公司 一种盐酸阿罗洛尔及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5175187A (en) * 1989-03-06 1992-12-29 Soorianarain Baligadoo Synergistic compositions for the treatment of coronary insufficiency and methods of use thereof
US5455269A (en) * 1989-03-06 1995-10-03 Baligadoo; Soorianarain Synergistic compositions of amiodarone and beta blockers
WO1992016197A1 (en) * 1991-03-18 1992-10-01 Sepracor Inc. Composition and method containing optically pure (s) metoprolol
JP2648897B2 (ja) * 1991-07-01 1997-09-03 塩野義製薬株式会社 ピリミジン誘導体
NO177455C (no) * 1993-06-04 1995-09-20 Gerrit Elmenhorst Anordning ved apparat for fremstilling av brannslukkende skum
WO1997038694A1 (en) * 1996-04-17 1997-10-23 Merck & Co., Inc. Combination therapy for reducing the risks associated with cardiovascular disease
SE9602762D0 (sv) * 1996-07-12 1996-07-12 Astra Ab Carton and blank for forming the same
US5998458A (en) * 1997-06-25 1999-12-07 University Technology Corporation Method of treating heart failure
GT199800126A (es) * 1997-08-29 2000-01-29 Terapia de combinacion.
EP1140187B1 (en) * 1998-12-23 2003-09-03 G.D. Searle LLC. Combinations of an ibat inhibitor and a mtp inhibitor for cardiovascular indications

Also Published As

Publication number Publication date
WO2001074394A1 (en) 2001-10-11
HUP0300332A3 (en) 2005-03-29
HUP0300332A2 (hu) 2003-06-28
US20030060477A1 (en) 2003-03-27
AU4298501A (en) 2001-10-15
CA2403160A1 (en) 2001-10-11
DE60125159T2 (de) 2007-10-25
EP1272219A1 (en) 2003-01-08
EE200200570A (et) 2004-04-15
CN1422161A (zh) 2003-06-04
JP2003528928A (ja) 2003-09-30
NO20024732D0 (no) 2002-10-02
ATE347909T1 (de) 2007-01-15
WO2001074394A8 (en) 2002-05-23
MXPA02009705A (es) 2004-02-26
MY136386A (en) 2008-09-30
EP1272219B1 (en) 2006-12-13
US20040192784A1 (en) 2004-09-30
SK14102002A3 (sk) 2003-06-03
RU2002123591A (ru) 2004-03-20
HK1051325A1 (en) 2003-08-01
IL151589A0 (en) 2003-04-10
BR0109753A (pt) 2003-02-04
KR20020086749A (ko) 2002-11-18
PL357813A1 (en) 2004-07-26
ES2276774T3 (es) 2007-07-01
NZ521351A (en) 2004-08-27
AU2001242985B2 (en) 2005-02-24
IS6554A (is) 2002-09-19
AR030414A1 (es) 2003-08-20
DE60125159D1 (de) 2007-01-25

Similar Documents

Publication Publication Date Title
NO20024732L (no) Ny kombinasjon av en betablokker og et kolesterolsenkende middel
DK1233964T3 (da) Ny anvendelse og hidtil ukendte N-azabicycloamidderivater
DE60141247D1 (de) Bandkassette und bandeinheit
NO20024874L (no) Benzoamidpiperidin-inneholdende forbindelser og beslektede forbindelser
IS6477A (is) Afleiður piperazíns og piperadíns
CY2012009I2 (el) Αναστολεις της κυκλοπροπυλ-συντηκωμενης διπεπτυλοπεπτιδασης 4, βασισμενοι σε πυρρολιδινη, και μεθοδοι για την παρασκευη των και την χρηση των
DK1210943T3 (da) Ny anvendelse af budesonid og formoterol
NO20014135D0 (no) Nye sulfonamidforbindelser og deres anvendelse
DE60103974D1 (de) Gyrase-inhibitoren und ihre verwendung
DE60132052D1 (de) Bohr- und Behandlungsflüssigkeiten
PT1100459E (pt) Preparacao oleosa espumante e sua utilizacao
NO20024709D0 (no) Borefluider og anvendelse derav
DE10196021T1 (de) Universeller Vermögenswert- und Beziehungsmanager
AU2001242985A1 (en) New combination of a betablocker and a cholesterol-lowering agent
DE60144529D1 (de) Bandkassette und bandeinheit
DE60131556D1 (de) Ringnetzwerk und datensender
IS5996A (is) Notkun á kólesteról lækkandi miðli
NO20030822D0 (no) Nye forbindelser og fremgangsmåter
NO20025509L (no) Ny polymorf av torasemid
EE200200703A (et) Beeta-blokaatorit ja vajadusel kolesterooli alandavat ainet sisaldav uus ravimvorm
NO20031369L (no) Kalium-kanal interagerende forbindelser, og anvendelser derav
NO20023243L (no) Ny terapeutisk anvendelse av enoxaparin
ZA200207107B (en) New combination of a betablocker and a cholesterol-lowering agent.
NO20035647D0 (no) Ny anvendelse av cyclolignaner og nye cycloliganer
FI991397A0 (fi) Petun uusi käyttö